Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Balmer

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 21, 2022
Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017Charles Nuttens, Jamie Findlow, Paul Balmer, et al.
FEMS Immunology and Medical Microbiology|September 13, 2006
Development and evaluation of a rapid multianalyte particle-based flow cytometric assay for the quantification of meningococcal serogroup B-specific IgM antibodies in sera for nonculture case confirmationGouri Laher, Paul Balmer, Steve J Gray, et al.
Advances in Therapy|September 4, 2013
A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitisMyint Tin Tin Htar, Harish Madhava, Paul Balmer, et al.
Vaccine|September 4, 2020
Broad vaccine protection against Neisseria meningitidis using factor H binding proteinJamie Findlow, Christopher D Bayliss, Peter T Beernink, et al.
Vaccine|June 12, 2002
Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infantsEmma Longworth, Ray Borrow, David Goldblatt, et al.
Infection and Immunity|December 23, 2003
Immune response to meningococcal serogroup C conjugate vaccine in asplenic individualsPaul Balmer, Michelle Falconer, Paula McDonald, et al.
Vaccine|May 30, 2006
Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunitySharif Uddin, Ray Borrow, Mansel R Haeney, et al.
Human Vaccines & Immunotherapeutics|September 8, 2023
Real-world impact and effectiveness of MenACWY-TTRodolfo Villena, Paula Kriz, Myint Tin Tin Htar, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayJamie Findlow, Ann Holland, Nick Andrews, et al.
Expert Review of Vaccines|April 26, 2022
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverageJamie Findlow, Ray Borrow, David S Stephens, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 21, 2022
Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017Charles Nuttens, Jamie Findlow, Paul Balmer, et al.
FEMS Immunology and Medical Microbiology|September 13, 2006
Development and evaluation of a rapid multianalyte particle-based flow cytometric assay for the quantification of meningococcal serogroup B-specific IgM antibodies in sera for nonculture case confirmationGouri Laher, Paul Balmer, Steve J Gray, et al.
Advances in Therapy|September 4, 2013
A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitisMyint Tin Tin Htar, Harish Madhava, Paul Balmer, et al.
Vaccine|September 4, 2020
Broad vaccine protection against Neisseria meningitidis using factor H binding proteinJamie Findlow, Christopher D Bayliss, Peter T Beernink, et al.
Vaccine|June 12, 2002
Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infantsEmma Longworth, Ray Borrow, David Goldblatt, et al.
Infection and Immunity|December 23, 2003
Immune response to meningococcal serogroup C conjugate vaccine in asplenic individualsPaul Balmer, Michelle Falconer, Paula McDonald, et al.
Vaccine|May 30, 2006
Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunitySharif Uddin, Ray Borrow, Mansel R Haeney, et al.
Human Vaccines & Immunotherapeutics|September 8, 2023
Real-world impact and effectiveness of MenACWY-TTRodolfo Villena, Paula Kriz, Myint Tin Tin Htar, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayJamie Findlow, Ann Holland, Nick Andrews, et al.
Expert Review of Vaccines|April 26, 2022
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverageJamie Findlow, Ray Borrow, David S Stephens, et al.
Pageof 8